These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8651607)

  • 1. NM23 in Ovarian Cancer. Correlation with clinicopathological and biochemical parameters.
    Ferrandina G; Scambia G; Marone M; Benedetti Panici P; Giannitelli C; Pernisco S; Coronetta F; Mancuso S
    Ann N Y Acad Sci; 1996 Apr; 784():509-12. PubMed ID: 8651607
    [No Abstract]   [Full Text] [Related]  

  • 2. The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
    Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
    Ann Oncol; 1999 Nov; 10(11):1335-41. PubMed ID: 10631462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.
    MacKinnon M; Kerr KM; King G; Kennedy MM; Cockburn JS; Jeffrey RR
    Eur J Cardiothorac Surg; 1997 May; 11(5):838-42. PubMed ID: 9196297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. nm23 protein expression in renal cell tumors: the role of the cell type.
    Ayhan A; Usubütün A; Ozen H; Yasui W; Tahara E
    Oncol Rep; 1998; 5(4):979-83. PubMed ID: 9625858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer.
    Katakura H; Tanaka F; Oyanagi H; Miyahara R; Yanagihara K; Otake Y; Wada H
    Ann Thorac Surg; 2002 Apr; 73(4):1060-4. PubMed ID: 11996241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival.
    Berney CR; Yang JL; Fisher RJ; Russell PJ; Crowe PJ
    World J Surg; 1998 May; 22(5):484-90. PubMed ID: 9564293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of nm23 gene expression in patients with ovarian cancer.
    Tas F; Tuzlali S; Aydiner A; Saip P; Salihoglu Y; Iplikci A; Topuz E
    Am J Clin Oncol; 2002 Apr; 25(2):164-7. PubMed ID: 11943895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
    Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
    Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.
    Kumar Dhar D; Kubota H; Tabara H; Kotoh T; Monden N; Igarashi M; Kohno H; Nagasue N
    Oncology; 1999; 56(2):122-8. PubMed ID: 9949298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
    Cao LQ; Chen XM; Li X
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical staining of nm23/nucleotide diphosphate kinase in invasive cervical carcinoma tissue and metastatic lymph nodes].
    Konno R; Sato S; Ito K; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Apr; 48(4):279-80. PubMed ID: 8936113
    [No Abstract]   [Full Text] [Related]  

  • 16. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma.
    Schneider J; Pollán M; Jiménez E; Marenbach K; Martínez N; Volm M; Marx D; Meden H
    Br J Cancer; 2000 May; 82(10):1662-70. PubMed ID: 10817501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
    Cheah PY; Cao X; Eu KW; Seow-Choen F
    Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study.
    Livingstone JI; Yasui W; Tahara E; Wastell C
    Br J Cancer; 1995 Oct; 72(4):976-80. PubMed ID: 7547252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. nm23 expression in advanced and borderline ovarian carcinoma.
    Schneider J; Romero H; Ruiz R; Centeno MM; Rodriguez-Escudero FJ
    Anticancer Res; 1996; 16(3A):1197-202. PubMed ID: 8702236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
    Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
    Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.